# CAR-T for r/r Malignant Tumors in Children

> **NCT04691349** · EARLY_PHASE1 · UNKNOWN · sponsor: **PersonGen BioTherapeutics (Suzhou) Co., Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- CAR-T
- Child, Only
- Malignant Tumor

## Interventions

- **DRUG:** CAR-T

## Key facts

- **NCT ID:** NCT04691349
- **Lead sponsor:** PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-27
- **Primary completion:** 2021-01-26
- **Final completion:** 2021-09-26
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04691349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04691349, "CAR-T for r/r Malignant Tumors in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04691349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*